Effects of beta interferon on concanavalin A binding and size of HeLa cells. 1982

L M Pfeffer, and I Tamm

Treatment of HeLa-S3 cells with 640 u/ml of human beta interferon (HuIFN-beta) in suspension culture increases the cell volume and the heterogeneity of the population with respect to cell size, as measured by Coulter electronic volume analysis. Based on such analysis, the cell surface area is increased 11% by 24 h, and 42% by 48 h after beginning of interferon treatment. Binding of [125I] Concanavalin A (measured at 22 degrees C) is increased 75% by 24 h, and 120% by 48 h on a per-cell basis. It follows that interferon treatment for 24 h causes a 58% increase in the abundance of functional Con A receptor sites per unit area of cell surface. The further increase in Con A binding after treatment of cells with interferon for 48 h can be attributed to increased surface area of cells.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D011952 Receptors, Concanavalin A Glycoprotein moieties on the surfaces of cell membranes that bind concanavalin A selectively; the number and location of the sites depends on the type and condition of the cell. Concanavalin A Binding Sites,Concanavalin A Receptors,Concanavalin A Receptor,Receptor, Concanavalin A
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L M Pfeffer, and I Tamm
March 1977, Biochemical and biophysical research communications,
L M Pfeffer, and I Tamm
April 1987, Nuklearmedizin. Nuclear medicine,
L M Pfeffer, and I Tamm
September 1974, Biochimica et biophysica acta,
L M Pfeffer, and I Tamm
December 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
L M Pfeffer, and I Tamm
August 2006, Journal of neuroimmunology,
L M Pfeffer, and I Tamm
January 1977, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
Copied contents to your clipboard!